Skip to content

Clinical trials

Nasopharyngeal Carcinoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nasopharyngeal Carcinoma Country / region: South Korea Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20181
20202
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BeiGene1
National Cancer Center, Japan1
Novartis Pharmaceuticals1
RAPT Therapeutics, Inc., a member of the GSK plc group of companies1
Sanofi1
Seoul National University Hospital1
Viracta Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nasopharyngeal Carcinoma7
Carcinoma, Non-Small-Cell Lung3
Squamous Cell Carcinoma of Head and Neck3
Nasopharyngeal Neoplasms2
Ovarian Neoplasms2
Triple Negative Breast Neoplasms2
Uterine Cervical Neoplasms2
Adenocarcinoma, Clear Cell1
Anus Neoplasms1
Breast Neoplasms1

Trials

Showing 76 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.